ANIP - ANI Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANIP is currently covered by 5 analysts with an average price target of $85.65. This is a potential upside of $16.44 (23.75%) from yesterday's end of day stock price of $69.21.

ANI Pharmaceuticals's activity chart (see below) currently has 50 price targets and 63 ratings on display. The stock rating distribution of ANIP is 10.34% HOLD and 89.66% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.82% with an average time for these price targets to be met of 263.38 days.

Highest price target for ANIP is $94, Lowest price target is $62, average price target is $73.4.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 11-Apr-2025. First documented stock forecast 15-Dec-2014.

Currently out of the existing stock ratings of ANIP, 3 are a HOLD (10.34%), 26 are a BUY (89.66%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$86

$16.79 (24.26%)

$86

9 days ago
(11-Apr-2025)

3/9 (33.33%)

$17.88 (26.25%)

89

Buy

$94

$24.79 (35.82%)

$94

1 months 3 days ago
(17-Mar-2025)

4/13 (30.77%)

$29.65 (46.08%)

148

Hold

$62

$-7.21 (-10.42%)

$60

5 months 29 days ago
(22-Oct-2024)

4/9 (44.44%)

$1.92 (3.20%)

52

Buy

$83

$13.79 (19.92%)

$49

7 months 2 days ago
(18-Sep-2024)

10/12 (83.33%)

$21.95 (35.95%)

474

Hold

$42

$-27.21 (-39.32%)

$40

1 years 11 months 12 days ago
(08-May-2023)

2/3 (66.67%)

$-0.58 (-1.36%)

274

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ANIP (ANI Pharmaceuticals) average time for price targets to be met?

On average it took 263.38 days on average for the stock forecasts to be realized with a an average price target met ratio 69.82

Which analyst has the current highest performing score on ANIP (ANI Pharmaceuticals) with a proven track record?

LOUISE CHEN

Which analyst has the current lower performing score on ANIP (ANI Pharmaceuticals) with a proven track record?

BRANDON FOLKES

Which analyst has the most public recommendations on ANIP (ANI Pharmaceuticals)?

Louise Chen works at SCOTIABANK and has 9 price targets and 5 ratings on ANIP

Which analyst is the currently most bullish on ANIP (ANI Pharmaceuticals)?

Oren Livnat with highest potential upside - $24.79

Which analyst is the currently most reserved on ANIP (ANI Pharmaceuticals)?

Brandon Folkes with lowest potential downside - -$27.21

ANI Pharmaceuticals in the News

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2025 financial results on Friday, May 9, 2025, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?